fda
4 records
FDA Device Recall: Orasure Technologies Interept Benzodiazopene Miro-Plate EIA-Benzo EIA 2 plate Ma
2020-09-02
Class III — Incorrect lot number for Standard Oral Fluid Negative Calibrator on specification sheet included in kit and/or additionally same error on unit box
View Source
FDA Device Recall: Barbiturates Intercept Micro-Plate EIA (enzyme immunoassay, barbiturate) Prod
2016-12-14
Class III — Shipping error. Cocaine metabolite Microplate distributed instead of Barbiturate Microplate due to incorrect selection of Microplate during manufacturing.
View Source
FDA Device Recall: OraQuick Ebola Rapid Antigen Test, Product Code 3001-2807; Intended for the q
2016-08-24
Class I — Failed stability testing at 8 months. This lot produced intermittent false negative results for the positive kit control with devices stored at 30C conditions.
View Source
FDA Device Recall: OraQuick HCV Visual Reference Panel Intended to assist new operation in beco
2016-04-27
Class III — OraSure Technologies, Inc. discovered the package insert included with the OraQuick HCV Rapid Antibody test Visual Reference Panel may be incorrect due to a complaint received from one of ...
View Source
lobbying
1 records
ny_corps
1 records
NY Corp: ORASURE TECHNOLOGIES, INC.
2000-10-06
FOREIGN BUSINESS CORPORATION | County: New York | Jurisdiction: Delaware
View Source
SEC EDGAR
1 records
sec_efts
1 records
SEC Filing: ORASURE TECHNOLOGIES INC
2024-03-11
SEC EDGAR filing — Forms: 10-K — Query: financial restatement
View Source
USASpending
2 records
Federal Award: ORASURE TECHNOLOGIES INC — $1,094,800
2022-06-22
THE PURPOSE OF THIS PURCHASE ORDER IS TO PROCURE ANTIBODY AND DIAGNOSTIC TESTS TO DETECT EBOLA VIRUS IN CADAVERS.
View Source
Federal Award: ORASURE TECHNOLOGIES INC — $10,568,608
2015-06-02
IGF::OT::IGF OBJECTIVE: MODIFY THE HIGHLY PROVEN ORAQUICK TEST PLATFORMTO ENABLE ANTIGEN DETECTION OF EBOLA ZAIRE FOR USE WITH AVARIETY OF SAMPLE TYPES: FINGERSTICK WHOLE BLOOD, PL
View Source
Be informed when major changes happen on C.F.A.I. — new data sources, platform updates, critical enforcement alerts
No spam. Only major updates. Unsubscribe anytime.